MedPath

Central Hemodynamics, Augmentation index and Microcirculation after Phlebotomy

Conditions
Augmentation indexCentral blood pressurePhlebotomyMicrocirculationPlasma viscocityAugmentatie indexCentrale bloeddrukAderlatingMicrocirculatiePlasmaviscociteit
Registration Number
NL-OMON27853
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
42
Inclusion Criteria

Patients aged 18-75 years receiving phlebotomy at regular intervals (for example because of hemochromatosis or polycythemia vera) ;

- Willing to participate ;

Exclusion Criteria

- Pacemaker or ICD device ;

- Atrial fibrillation ;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The principal endpoint is defined as the difference in AIx (≥4%) before and after phlebotomy while standing.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath